Introduction

Pediatric pulmonary vein stenosis radiation dose optimization has emerged as a critical priority in congenital interventional cardiology as transcatheter management of this lethal condition migrates from experimental therapy to established clinical practice. Pulmonary vein stenosis—whether primary (congenital) or secondary (post-surgical, post-transplant, or post-radiofrequency ablation)—progresses inexorably without intervention, causing pulmonary hypertension, right heart failure, and death within months of diagnosis. Transcatheter balloon dilatation and, increasingly, cutting-balloon angioplasty with stent deployment offer palliative relief, but the nature of the disease mandates repeated interventions at 3–6 month intervals as restenosis inevitably occurs.[1]

The cumulative radiation burden from these serial procedures is staggering. A neonate who undergoes eight PVS dilatations across the first two years of life may accumulate air kerma values that approach deterministic skin injury thresholds if unoptimized protocols are used. For pediatric interventional cardiologists, radiographers, and cath lab administrators, mastering dose reduction during PVS interventions is therefore not an optional refinement but a clinical obligation. The stochastic risks of ionizing radiation—thyroid malignancy, breast cancer, and leukaemia—are amplified in children by their 2–3× greater radiosensitivity per unit dose and their longer post-exposure lifespan for latent cancer development.[2] This article presents a comprehensive, evidence-based fluoroscopy protocol for pediatric pulmonary vein stenosis radiation dose optimization, integrating projection selection, biplane acquisition, exposure parameter modulation, fluoroscopy loop recording, and scatter protection with SATPRO bismuth drapes.

Anatomy and pathophysiology of pulmonary vein stenosis

Embryological origins and anatomical patterns

Pulmonary vein stenosis arises from abnormal incorporation of the pulmonary venous confluence into the posterior left atrium during cardiac development. In normal embryogenesis, the common pulmonary vein evaginates from the dorsal atrial wall and connects with the splanchnic plexus, which ultimately forms the four individual pulmonary veins. Failure of this process results in stenosis at the veno-atrial junction, within the vein itself, or at the level of the intrapulmonary venous branches.[3]

Four anatomical patterns are recognized. Type I (isolated stenosis) involves a single pulmonary vein with discrete narrowing at the atrial junction. Type II (diffuse hypoplasia) affects the entire length of one or more veins, often with associated pulmonary venous return anomalies. Type III (post-surgical stenosis) occurs at suture lines following total anomalous pulmonary venous return (TAPVR) repair, Senning or Mustard procedures, or cardiac transplantation. Type IV (progressive intimal proliferation) is characterized by aggressive fibromyxoid intimal hyperplasia that extends into the intrapulmonary venous branches, creating a "tree-in-bud" pattern on CT angiography.[4]

The anatomical complexity of PVS directly influences fluoroscopy demand. Type I lesions may require only a single balloon dilatation with modest cine acquisition. Type III and IV lesions, which often involve multiple veins, diffuse narrowing, and recurrent restenosis, demand extensive angiographic mapping, repeated balloon sizing, and multiple stent deployments across separate procedures. Each additional vein treated adds approximately 15–20 minutes of fluoroscopy time and 3–5 cine acquisitions, escalating the pediatric pulmonary vein stenosis radiation dose disproportionately.

Hemodynamic consequences and natural history

The hemodynamic consequences of PVS are determined by the number of veins affected, the severity of narrowing, and the presence of collateral venous drainage. Single-vein stenosis with three patent veins may be well tolerated initially, but progressive stenosis of a second vein precipitates dramatic pulmonary hypertension and right ventricular dysfunction. Bilateral severe PVS is almost universally fatal without intervention, with median survival of 4–6 months from diagnosis in untreated neonates.[5]

The natural history of post-surgical PVS is particularly relevant to dose management. Following TAPVR repair, 10–15% of patients develop progressive stenosis at the anastomotic site, with the highest risk in the first 6–12 months post-operatively. These patients require serial catheterizations for surveillance and intervention, creating a predictable trajectory of cumulative radiation exposure. Dose optimization in the first procedure sets the trajectory for all subsequent interventions; a high-exposure initial protocol compounds across the entire treatment course.

Interventional indications and procedural workflow

Balloon dilatation and cutting-balloon angioplasty

Transcatheter balloon dilatation remains the first-line intervention for accessible stenotic lesions. The procedure involves femoral venous access, transseptal puncture (if necessary), selective engagement of the stenotic pulmonary vein, and balloon inflation across the narrowed segment. Standard balloon sizes range from 4–10 mm diameter, with inflation pressures of 4–8 atmospheres maintained for 15–30 seconds.[6] Cutting-balloon angioplasty, which uses microsurgical blades mounted on the balloon surface, has shown superior acute results in resistant lesions by creating controlled intimal dissection that reduces elastic recoil.

Each dilatation requires precise fluoroscopic guidance. The balloon must be positioned with the stenotic segment centred along its length, requiring high-resolution magnification and often biplane confirmation. Inflation must be monitored in real time to detect balloon waist persistence (indicating inadequate dilatation) or sudden loss of waist (indicating vessel rupture risk). Post-dilatation angiography in at least two orthogonal projections is mandatory to assess for dissection, perforation, or thrombus formation. The cumulative effect is that a single-vein PVS dilatation typically requires 20–30 minutes of fluoroscopy and 4–6 cine acquisitions.

Stent deployment and re-dilatation

Stent deployment is indicated for elastic recoil after balloon dilatation, recurrent restenosis within 3 months, or long-segment hypoplasia (>10 mm). Coronary stents (2.5–4 mm diameter) are used for small veins in infants, while larger peripheral stents (5–8 mm) may be deployed in older children. The procedure demands exact positioning: the stent must cover the entire stenotic segment with 2–3 mm margins on either side, yet avoid protrusion into the left atrium (which risks thrombus formation) or extension into the intrapulmonary branches (which may occlude side branches).[7]

Stent deployment is the most fluoroscopy-intensive phase of PVS intervention. Pre-deployment sizing requires calibrated angiography in two orthogonal planes. Deployment itself is performed under continuous magnified fluoroscopy to confirm stent expansion and apposition. Post-deployment balloon dilatation ("flaring") requires additional real-time monitoring. For multi-vein disease, the procedure is repeated sequentially, with each vein adding 30–45 minutes to total fluoroscopy time. Without dose optimization, pediatric pulmonary vein stenosis radiation dose from a multi-vein stenting procedure can exceed 1.5 Gy air kerma.

Projection optimization for dose reduction

Straight AP and procedure-specific oblique views

The single most effective strategy for reducing pediatric pulmonary vein stenosis radiation dose is projection optimization. The neonatal and infant chest has minimal tissue attenuation, and the straight anteroposterior (AP, 0°) projection provides the shortest beam path through the thorax. For the majority of PVS interventions, AP or shallow cranial/caudal angulation (≤15°) provides adequate visualization of the pulmonary venous confluence and left atrium while reducing entrance skin dose by 20–30% compared with steep oblique views.[8]

However, the pulmonary veins exit the left atrium posteriorly and course obliquely toward the hila, making pure AP inadequate for full-length visualization. Left pulmonary vein stenosis is best profiled in LAO 40° with 20° cranial angulation, which separates the left upper and lower pulmonary veins from the cardiac silhouette and profiles the veno-atrial junction perpendicular to the X-ray beam. Right pulmonary vein stenosis is best visualized in RAO 30° with 15° caudal angulation, which similarly profiles the right-sided veins against the relatively radiolucent lung field.[9]

The protocol mandates that these steep oblique projections be reserved for two specific moments only: (1) definitive diagnostic angiography to define stenosis severity and length, and (2) post-intervention assessment to confirm procedural success. All preparatory steps—transseptal puncture, catheter advancement, wire exchanges, and balloon positioning—should be performed in AP or shallow LAO/RAO (≤15°). This projection minimization strategy can reduce total fluoroscopy time by 15–20% and cine acquisition count by 30–40%.

Pre-procedural CT-based projection planning

Pre-procedural cardiac CT angiography has transformed projection planning for PVS interventions. Three-dimensional volume-rendered reconstructions allow operators to identify the optimal working angle that profiles each stenotic vein perpendicular to the X-ray beam before the patient enters the cath lab. This "virtual angiography" approach eliminates the trial-and-error C-arm rotation that characterizes conventional PVS cases, reducing both fluoroscopy time and the number of diagnostic cine runs.[10] In centres without pre-procedural CT, the initial diagnostic run in AP should be used to plan subsequent oblique angles, with angles documented and reused for follow-up procedures rather than redetermined each time.

Exposure parameters and pediatric golden rules

Neonatal and infant exposure settings

Pediatric PVS interventions demand fundamentally different exposure parameters from adult practice. The default adult protocol would deliver catastrophic dose to a neonatal chest. The protocol for pediatric pulmonary vein stenosis radiation dose optimization mandates pulsed fluoroscopy at 3.75 fps for all phases of the procedure, with tube potential reduced to 50–60 kV and tube current to 5–25 mA for neonates and infants under 1 year.[11]

For children aged 1–10 years, tube potential can be increased to 60–70 kV with 20–60 mA, reflecting the modest increase in thoracic tissue thickness. However, the pulse rate should remain at 3.75 fps for all non-critical phases. At this frame rate, temporal resolution remains adequate for balloon and stent visualization while reducing dose rate by 50–75% compared with 7.5 fps and by 80–90% compared with 15 fps continuous mode. The only exception is the critical moment of stent deployment, where 7.5 fps may be briefly activated to confirm precise positioning before release.

High contrast-to-noise presets

Modern angiography systems offer procedure-specific image processing presets that optimize contrast-to-noise ratio (CNR) for specific anatomical targets. For PVS interventions, the high CNR preset should be selected before the procedure begins. This preset enhances edge detection in low-contrast structures such as pulmonary veins, which are surrounded by aerated lung and contain oxygenated blood with lower iodine concentration than systemic arteries. By improving CNR at the image processing level, the high CNR preset allows operators to accept lower entrance dose while maintaining diagnostic confidence.[12]

The combination of low kV (50–60 kV in neonates), which maximizes iodine contrast attenuation, with high CNR post-processing creates an optimal imaging chain for PVS visualization. This approach is particularly valuable in post-operative patients, where surgical clips, sternal wires, and chest tubes create metallic artifacts that degrade image quality. The high CNR preset partially compensates for these artifacts, reducing the temptation to increase exposure parameters for better visualization.

Biplane acquisition and fluoroscopy loop recording

Synchronized biplane angiography

Biplane angiography is transformative for reducing pediatric pulmonary vein stenosis radiation dose in multi-vein disease. By acquiring two orthogonal projections simultaneously, biplane systems halve the number of cine runs required for diagnostic assessment and post-intervention confirmation. For a four-vein PVS case, conventional single-plane angiography requires eight cine runs (two projections per vein) for complete assessment. Biplane acquisition reduces this to four runs, cutting cine dose by 50%.[13]

The technical requirements for effective biplane PVS imaging are specific. The two C-arms must be synchronized to trigger simultaneously, with identical exposure parameters on both planes. The primary plane (typically LAO 40°/cranial 20° for left veins, RAO 30°/caudal 15° for right veins) is optimized for the stenotic segment, while the secondary plane (typically orthogonal shallow RAO or LAO) provides spatial context. Both planes should use identical kV, mA, and pulse rate settings to ensure comparable image quality. Asymmetric exposure settings—where one plane uses higher parameters than the other—defeat the dose-reduction purpose and should be avoided.

Fluoroscopy loop recording

Fluoroscopy loop recording—storing high-quality fluoroscopy sequences for later review rather than acquiring formal cine runs—is one of the most underutilized dose reduction strategies in pediatric interventional cardiology. Modern angiography systems can record fluoroscopy loops at diagnostic quality (equivalent to 7.5 fps cine) while delivering only 20–30% of the dose of a standard cine acquisition. These loops can be reviewed immediately after the procedure, archived for documentation, and used for procedural teaching and quality assurance.[14]

For PVS interventions, fluoroscopy loop recording should replace cine for all non-diagnostic phases: transseptal puncture, catheter advancement, wire exchanges, balloon positioning, and stent delivery. Cine acquisition should be reserved for three specific moments: (1) baseline diagnostic angiography, (2) post-dilatation or post-stenting assessment, and (3) emergency bail-out situations where immediate high-resolution documentation is required. This "cine-sparing" approach can reduce total cine acquisition count by 60–70% in experienced centres.

Scatter mitigation with SATPRO protection

Source-based scatter attenuation in pediatric PVS procedures

Scatter radiation poses a dual hazard in pediatric PVS interventions: it elevates operator dose and increases patient entrance dose through backscatter. The operator, positioned on the patient's right side for femoral venous access, receives the highest scatter dose when the tube is in LAO projection, which is required for left pulmonary vein visualization. In neonatal cases, where the tube is positioned close to the patient to minimize source-to-image distance, operator hand dose can approach action levels during prolonged multi-vein procedures.[15]

SATPRO lead-free bismuth drapes are designed to attenuate this scatter at its origin. For pediatric PVS interventions, the drape should be positioned around:

• The entire torso, covering the chest wall from clavicles to the lower abdomen, to intercept lateral scatter from the lung fields.
• The upper back and shoulders, where posterior scatter accumulates during AP and cranial angulation.
• The groin access lines, to protect against backscatter from the femoral venous entry site.

The SATPRO sterile scatter drape is formulated with bismuth oxide particles suspended in a polymer matrix, providing attenuation equivalent to 0.5 mm lead without the weight or toxicity. For PVS procedures, which often exceed 60 minutes in multi-vein cases, the drape should be placed before the patient is draped for sterility, ensuring continuous protection throughout the case. Clinical phantom studies demonstrate that SATPRO drapes reduce operator hand dose by 55–65% during prolonged structural procedures and lower patient backscatter dose by 15–20%.[16]

Shielding configuration for biplane PVS procedures

Biplane PVS interventions present unique shielding challenges because the two X-ray tubes operate simultaneously from different angles. The primary tube (typically LAO for left veins) generates left-sided scatter, while the secondary tube (orthogonal RAO) generates right-sided scatter. A full-torso SATPRO drape, combined with ceiling-suspended lead acrylic shields positioned on both sides of the table, creates comprehensive protection. The lead acrylic shield between the primary operator and the patient should be positioned at 45° to intercept scatter from both tubes.[17]

The protocol emphasizes that personal protective equipment—lead aprons (minimum 0.5 mm lead equivalent), thyroid shields, and lead glasses—remains mandatory regardless of patient draping. SATPRO reduces the scatter load, but does not eliminate it. In high-volume pediatric centres performing more than 50 complex PVS interventions annually, the combination of SATPRO draping, lead acrylic shields, and dosimetry feedback has been shown to keep operator whole-body dose below 1 mSv per year.

Dose monitoring and cumulative tracking

Real-time dose feedback

Systematic dose monitoring is essential for any programme performing pediatric PVS interventions. Every case should generate a dose report including: total fluoroscopy time, number and duration of cine runs, cumulative air kerma (K_a,r), kerma-area product (P_KA), and peak skin dose estimate. In pediatric practice, these data take on heightened importance because patients will return for repeated procedures at 3–6 month intervals, creating a predictable trajectory of cumulative exposure.[18]

Real-time dose displays, positioned in the operator's direct line of sight, have been shown to reduce exposure by 15–25% through behavioural modification alone. In pediatric PVS cases, where the psychological threshold for concern is lower due to the patient's small size, real-time feedback is particularly effective: operators naturally reduce fluoroscopy time and cine acquisition when they see cumulative dose approaching institutional alert levels.[19]

Cumulative dose registries and longitudinal tracking

Pediatric cardiac centres should maintain a dedicated cumulative dose registry for every patient undergoing PVS interventions. This registry should track total air kerma, total PKA, and estimated peak skin dose across all catheterization episodes. Alert thresholds should be established at 50% and 75% of accepted lifetime limits, triggering mandatory review of future procedural planning. For patients with progressive PVS who may undergo 8–10 procedures across childhood, cumulative tracking is the only mechanism to prevent deterministic skin injury and manage stochastic risk.[20]

The following diagnostic reference levels are proposed for pediatric PVS interventions based on current literature and institutional best practice:

Conclusion

Pediatric pulmonary vein stenosis interventions—balloon dilatation, cutting-balloon angioplasty, and stent deployment—represent some of the most fluoroscopy-intensive and radiation-sensitive procedures in congenital interventional cardiology. The nature of the disease, with its inexorable progression and high restenosis rate, mandates repeated interventions at 3–6 month intervals, creating a cumulative radiation burden that can approach deterministic skin injury thresholds across a patient's treatment course. For neonates and infants, whose tissues are 2–3 times more radiosensitive per unit dose than adults, every milligray of unnecessary exposure contributes measurably to lifetime cancer risk.

The protocol presented here integrates five pillars of dose reduction: projection optimization (straight AP for the majority of device manipulation, with steep obliques reserved for diagnostic and confirmatory phases only), biplane acquisition synchronization (halving the number of cine runs required for multi-vein assessment), exposure parameter modulation (pulsed fluoroscopy at 3.75 fps, 50–70 kV, and 5–60 mA with high CNR presets), fluoroscopy loop recording (replacing cine for all non-diagnostic phases), and scatter mitigation (SATPRO lead-free bismuth drapes, tight micro-collimation, and strategic shielding). Together, these measures can reduce cumulative air kerma by 50–60% compared with unoptimized pediatric workflows, without compromising procedural precision or safety.

For neonates and infants, the emphasis must remain on anti-scatter grid removal, low frame rates, aggressive micro-collimation, and copper spectral filtration as the foundational dose reduction strategies. For older children, the principles remain identical, with modest increases in kV and mA reflecting greater tissue thickness. The use of documented projection angles from prior procedures, biplane acquisition, and fluoroscopy loop recording to eliminate redundant cine runs, combined with cumulative dose registries that track exposure across a patient's entire interventional history, ensures that radiation safety is managed as a longitudinal priority rather than a per-procedure afterthought.

Ultimately, radiation safety in pediatric pulmonary vein stenosis interventions is not achieved by any single technique, but by the systematic application of ALARA principles at every step—from pre-procedural planning through final stent deployment. Institutions that adopt structured dose-monitoring, operator feedback loops, and standardized pediatric scatter-protection protocols will see the greatest reductions in long-term stochastic risk for both patients and catheterization laboratory staff. For children facing the daunting prospect of repeated cardiac catheterizations, this commitment to dose optimization is not merely best practice—it is a clinical and ethical obligation.

Further reading

References